2021
DOI: 10.1002/ijgo.13514
|View full text |Cite
|
Sign up to set email alerts
|

Effects of selenium supplementation on pregnancy outcomes and disease progression in HIV‐infected pregnant women in Lagos: A randomized controlled trial

Abstract: Objective To examine the effects of selenium supplementation on pregnancy outcomes and disease progression among HIV‐infected pregnant women in Lagos. Methods A randomized, placebo‐controlled trial conducted among HIV‐positive pregnant women between September 2018 and August 2019. At enrollment, 90 women were randomly assigned into each treatment arm to receive either a daily tablet of 200 μg elemental selenium or a placebo. Relevant participants' sociodemographic and clinical data were collected at enrollment… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(21 citation statements)
references
References 22 publications
0
14
0
Order By: Relevance
“…These results confirm the important role of selenium, even if administered along with a multivitamin, in the maintenance of the immune system [ 223 ]. Specific trials on HIV-infected pregnant women show neither amelioration on the CD4+ cell count [ 217 ] nor decrease in the preterm delivery [ 224 ]. However, this may be due to the poor baseline nutritional status of the considered patients.…”
Section: Hivmentioning
confidence: 99%
“…These results confirm the important role of selenium, even if administered along with a multivitamin, in the maintenance of the immune system [ 223 ]. Specific trials on HIV-infected pregnant women show neither amelioration on the CD4+ cell count [ 217 ] nor decrease in the preterm delivery [ 224 ]. However, this may be due to the poor baseline nutritional status of the considered patients.…”
Section: Hivmentioning
confidence: 99%
“…Included studies were performed in seven different countries and 18 were primary [ 34 39 , 41 48 , 51 , 53 55 ] while four were secondary studies [ 40 , 49 , 50 , 52 ]. Ten studies were graded as fair [ 34 , 36 , 37 , 39 , 41 43 , 48 , 50 , 53 ], nine as good [ 35 , 38 , 40 , 45 , 49 , 51 , 52 , 54 , 55 ], and three as excellent quality [ 44 , 46 , 47 ] ( Figure 2 ). Seventeen studies reported maternal outcomes, two reported neonatal outcomes, and three reported both.…”
Section: Resultsmentioning
confidence: 99%
“…The third trial, of excellent quality, reported that Se supplementation significantly lowered the risk of preterm delivery (relative risk 0.32, 95% confidence interval 0.11–0.96) compared to placebo. But it did not affect HIV-disease progression in pregnant women, as evidenced by no significant changes in CD4+ cell count [ 46 ].…”
Section: Resultsmentioning
confidence: 99%
“…Similarly, low selenium levels in HIV-infected mothers increase the risk of preterm birth and the delivery of low-birth-weight neonates. Okunade et al [48] undertook a study looking at the effects of selenium supplementation on pregnancy outcomes and disease progression in a Nigerian population of HIV-infected pregnant women. A total of 90 women were randomly assigned to receive either a daily 200 µg selenium or placebo tablet.…”
Section: Seleniummentioning
confidence: 99%
“…In Section 3.7, a study by Okunade et al [48] is referred, which demonstrated in a Nigerian population of HIV-infected pregnant women that selenium lowered the risk of preterm delivery, but had no effects on disease progression.…”
Section: Micronutrients Malaria and Hivmentioning
confidence: 99%